Introduction
Numerous reports have documented the release of folliclestimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary in animals and humans in response to stimulation with natural or synthetic hypothalamic LH-and FSHreleasing hormone (FSH/LH-RH). Schally et al., 1971 a; Schally et al., 1971 b). It has been clearly shown that the pituitary gland releases mostly LH but also FSH after FSH/LH-RH is injected subcutaneously, intramuscularly, or intravenously. The respon.:e seems to be doserelated. Endogenous FSH and LH released under these conditions stimulate the gonads, as shown by the steroids secreted. Kastin et al., 1972 b; Yen et al., 1972; Zarate et al., 1972) . The study of the gonadal response from the viewpoint of ovulation or spermatogenesis, however, is most important for further assessment of the true potential value of FSH/LH-RH in the treatment of sterility and infertility. (Zarate et al., 1972; Akande et al., 1972) .
Pituitary gonadotrophic hormones have both a mitotic action, stimulating follicular growth, and a steroidogenic effect. When the mature follicle is ripe LH forces its rupture and the ovum is released. Since the release of FSH and LH and the resulting hormonal changes in the gonads after injection of FSH/LH-RH have been shown in man and other mammals, we felt that it would be interesting to study the follicular growth and the mitotic and ovulatory response at the ovarian level after FSH/LH-RH stimulation. Modifications which resulted from the steroidal response in other indirect indices were also investigated. In carrying out the study we used an experimental model in which constant iatrogenic anovulation existed as a result of the administration of injectable depot medroxyprogesterone acetate (MPA) and depot chlormadinone acetate (CA) for contraceptive purposes. We expected that more information could be obtained about the effect of FSH/LH-RH on human ovaries and ovulation by directly observing both ovaries at a laparotomy performed for elective tubal sterilization. We thought this could be substantiated by histological and histochemical studies of the structures stimulated and by a comparison with findings in untreated controls.
Patients and Methods
Fifty-seven apparently healthy women, aged 20 to 42 years and known to be fertile, participated in the study. They had all asked for tubal sterilization because of high multiparity. In each case both the husband and the wife had signed a request form after an attending physician and social worker had explained the surgical procedure. The whole investigation was considered and approved by a specially appointed ethical committee at the University Maternity Hospital. Each case had to be approved by at least four of the six physicians on the committee. The clinician in charge carefully explained the preoperative studies to each patient and that at operation a wedge biopsy would be made of one ovary and that one oviduct would be removed for morphophysiological studies.
We assumed from their previous pregnancies that all the women had a normally functioning hypothalamic-pituitarygonadal axis. Constant iatrogenic anovulation as a contraceptive measure was then induced in all of them by the administration of either long-acting depot MPA or depot CA. The MPA was injected intramuscularly in doses of 250 or 300 mg every six months or 150 mg every three months, the CA in doses of 250 mg every two-and-a-half to three months or 150 mg every two months. These progestogens are potent contraceptives. (Zanartu et al., 1970; Zanartu and Onetto, 1974) .
The 57 participants were divided into a control group and an experimental group. The control group consisted of 41 women who had been on the contraceptive regimen for more than 12 months. They were then examined at laparotomy for tubal sterilization or for therapeutic hysterectomy. The experimental group consisted of 16 women who had also followed the contraceptive regimen. While they were still affected by the MPA or CA-as shown by marked progestational modifications in such target organs as vagina, cervix, and endometrium-they were given stimulatory treatment with synthetic hypothalamic FSH/ LH-RH. The substance used was a decapeptide with the composition and amino-acid sequence described by Schally et al. (1971 b, and Because of reports that intravenous infusions were most effective (Zarate et al., 1972 ) the first trials were with five-to seven-hour intravenous infusions every second day. Because this proved inconvenient to patients, however, and because it failed to elicit any marked oestrogenic response, we adopted a regimen of one daily intramuscular injection for seven to 20 days followed by a single intravenous infusion once the intramuscular treatment had induced modifications in the cervical and vaginal indices suggesting endogenous oestrogen secretion. Subsequently we increased the number of intramuscular injections to two a day for the same number of days before giving the single intravenous infusion.
Several criteria were used in deciding when to change from intramuscular injections to intravenous infusions. Endogenous progesterone secretion was estimated from 24-hour urinary pregnanediol excretion, which was routinely studied the day before treatment and before laparotomy, using a thin-layer chromatography method (Sulimovici et al., 1965) . The endogenous secretion of oestrogens was evaluated indirectly by biological criteria (vaginal cytology and kariopicnotic index, modifications in the physico-chemical properties of cervical mucus, and cervical os opening). An endometrial biopsy was taken the day before laparotomy.
After treatment the patients were explored at laparotomy 12 hours to 11 days after the final dose of FSH/LH-RH. The uterus, oviducts, and both ovaries were examined by direct visual and manual inspection. The presence of bloody fluid in the peritoneal cavity (pouch of Douglas), signs of ovulation, corpus luteum, cystic follicles, follicular cysts, or an apparently mature follicle were carefully recorded. Photographs were taken in all cases. A wedge biopsy was made in the ovary containing the functional structures estimated to be most significant-that is, mature follicle, corpus luteum, cystic follicle, and follicular cyst. The tissue sample was divided into two portions: one for histological study and the other, frozen with dry ice and sectioned at 16 microns thickness in a cryostat at minus 200C, for investigation of enzyme activity related to delta-5,3-betahydroxysteroid dehydrogenase (3-p-OHD) and 20-alphahydroxysteroid dehydrogenase (20-a-OHD). The methods we used have been described elsewhere (Zanartu et al., 1970) and also our classification of the follicular apparatus (Zanartu et al., 1970; Zanartu and Onetto, 1974) . BRITISH MEDICAL JOURNAL 30 MARCH 1974 The diagnosis of a fully mature, non-ruptured follicle was based on the macroscopic aspect and the histologic evidence of well-developed granulosa cells and internal and external theca cell layers. The presence of numerous mitoses in these cells was considered an important sign of gonadotrophic stimulation. They were counted on tissue sections by a semi-quantitative method and recorded in arbitrary units (0 to 3+).
Results

CONTROL GROUP
At laparotomy the ovaries of women in the control group appeared normal in shape but they were about two-thirds of the normal ovulatory size (table I). They were whitish in colour, had a smooth surface, and contained from one to three cystic follicles and, occasionally, one or two follicular cysts. No evidence of ovulation or corpus luteum was seen on direct inspection or microscopically (Zanartu et al., 1970; Zanartu and Onetto, 1974) . Though there were normal-appearing follicles up to the Graafian stage and atretic follicles there was no mitosis nor was enzymatic activity of steroid-converting dehydrogenases (3-,-OHD or 20-m-OHD) eYer present.
It was assumed from these findings that the ovaries were in a "resting," anovulatory condition. This was shown by the fact that though follicular growth up to the Graafian stage persisted and there was some luteinization of the theca there was no evidence of steroid-converting dehydrogenase activity.
EXPERIMENTAL GROUP All patients in the experimental group, whose ovaries had been stimulated by FSH/LH-RH, presented slight to marked evidence of ovarian stimulation in terms of size. The ovaries consisted of a number of cystic follicles. In two patients there was bloody fluid in the peritoneal cavity. A congested uterus, oviducts, and ovaries were found in the presence of a mature follicle or fresh corpus luteum in five women. Biopsy confirmed the existence of fresh haemorrhagic corpus luteum in two patients. In three further patients the biopsy tissue contained luteinized follicles with well-developed theca and granulosa cells and with mitosis (1 + to 2+). In these structures steroidconverting dehydrogenase activity for 3-p-OHD was positive.
The stimulatory effect of FSH/LH-RH manifested itself in mild to moderate signs of oestrogenic changes in the vaginal cytology and cervical gland secretion, with a switch from progestational to oestrogenic characteristics. Endometrial histology, however, was not modified. It was also apparent that the intramuscular injection of synthetic FSH/LH-RH caused definiite stimulation in "resting" ovaries with suppressed ovulation in terms of mitotic and steroidogenic FSH-and LH-like effects in those women receiving the optimum dosage ( contraceptive for at least six months when administered in doses Under these experimental conditions the ovulation rate was of 250 or 300 mg intramuscularly and is effective for at least less than 30% even when the preovulatory follicles were counted.
three months in doses of 150 mg intramuscularly. The period of
We are now trying to determine whether prolonged stimulation ovulation inhibition was two months for 150 mg CA intrawith FSH/LH-RH would induce more ovulations. Up to five muscularly and three months for 250 mg CA intramuscularly.
prolonged intravenous infusions of 0-5 mg FSH/LH-RH proAt the end of these periods spontaneous ovulation tends to duced only a preovulatory follicle in one patient. Numerous reappear (Zanartu et al., 1970) . We therefore assume that it mitoses and granulosa cells were present. The optimum stimuwould be easier to induce ovulation towards the end of the lation was apparently produced by giving small intramuscular period during which the anovulatory agents remained active.
injections repeated every 12 hours until signs of follicular Our findings in this admittedly limited study, however, do not maturation presented and then a booster dose of 0-5 mg by confirm this hypothesis. While they confirm the FSH-and LHintravenous infusion.
releasing effect of the synthetic hypothalamic hormone, there These preliminary observations suggest that repeated smallwas much individual variation in the response to stimulation.
dose stimulation is more effective than larger single doses. These variations seemed totally unrelated to the anovulatory Earlier investigations also suggest that prolonged intravenous agent itself or to the time after the last dose of MPA or CA at infusions may be as effective as small intramuscular doses which the stimulatory agent was given (table III). repeated every six or eight hours daily. These findings point to Evidently a total dose of FSH/LH-RH of less than 1-0 mg, a prolonged and continuous FSH/LH-RH stimulation for a even if given by slow intravenous infusion, had only a weak period of 10 or more days as a possible means of stimulating ovarian stimulatory effect under our experimental conditions. follicular growth and increasing the ovulation rate. Our findings On the other hand, rather high doses (2-1 to 2-6 mg) were more suggest that a long-acting depot preparation of FSH/LH-RH effective and they did not produce a hyperstimulation syndrome would be more convenient for therapeutic use. in the four women to whom they were given. In three women The fact that treatment with FSH/LH-RH induced ovulation we were able to induce preovulatory follicles characterized by and development of the corpus luteum in some of our patients well-developed and evenly distributed granulosa and theca cell supports the view that it may prove valuable in patients with layers, with mitosis and signs of extemal theca vascularization, anovulatory sterility of hypothalamic origin. We would emphaand in two further patients the treatment brought about fresh size, however, that we have not yet found a therapeutic regimen haemorrhagic corpora lutea.
with this agent that consistently gives an ovulation rate similar 
